Treatment success rate for patients treated for MDR-TB in Iran, Islamic Republic of
Iran, Islamic Republic of: Treatment success rate for patients treated for MDR-TB was 72.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in Iran, Islamic Republic of, 2002–2022
Source: World Health Organization, Global Health Observatory.
Analysis
Iran, Islamic Republic of recorded 72.0% for treatment success rate for patients treated for mdr-tb in 2022.
The figure is down 1.4% on the previous year and up 50.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Iran, Islamic Republic of peaked at 74.0% in 2013 and was at its lowest, 23.0%, in 2006.
Iran, Islamic Republic of ranks 87th of 163 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Treatment success rate for patients treated for MDR-TB in Iran, Islamic Republic of, year by year
| Year | Value | Change |
|---|---|---|
| 2002 | 33.0% | — |
| 2006 | 23.0% | -30.3% |
| 2007 | 51.0% | +121.7% |
| 2008 | 36.0% | -29.4% |
| 2009 | 42.0% | +16.7% |
| 2010 | 41.0% | -2.4% |
| 2011 | 68.0% | +65.9% |
| 2012 | 48.0% | -29.4% |
| 2013 | 74.0% | +54.2% |
| 2014 | 58.0% | -21.6% |
| 2015 | 63.0% | +8.6% |
| 2016 | 55.0% | -12.7% |
| 2017 | 59.0% | +7.3% |
| 2018 | 60.0% | +1.7% |
| 2019 | 54.0% | -10.0% |
| 2020 | 60.0% | +11.1% |
| 2021 | 73.0% | +21.7% |
| 2022 | 72.0% | -1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 37.0% | 23.0% | 51.0% | 5 |
| 2010s | 58.0% | 41.0% | 74.0% | 10 |
| 2020s | 68.3% | 60.0% | 73.0% | 3 |
Countries ranked near Iran, Islamic Republic of
- 87 Afghanistan 72.0% compare
- 87 Niger 72.0% compare
- 87 Hong Kong, China 72.0% compare
More health data for Iran, Islamic Republic of
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0378 units per person (2025)
- Population ages 05-09, male, annual growth rate -3.77 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0399 units per person (2025)
- Population ages 10-14, female, annual growth rate 2.67 % change on previous year (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Iran, Islamic Republic of?
- Treatment success rate for patients treated for mdr-tb in Iran, Islamic Republic of was 72.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Iran, Islamic Republic of?
- The highest recorded value was 74.0% in 2013.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Iran, Islamic Republic of?
- The lowest recorded value was 23.0% in 2006.
- How does Iran, Islamic Republic of rank for treatment success rate for patients treated for mdr-tb?
- Iran, Islamic Republic of ranks 87th out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Iran, Islamic Republic of?
- Over the last ten years it is up 50.0%. The long-run trend across the full record is rising.
- Where does this Iran, Islamic Republic of data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).